Regualtory Assessment | Gap Analysis

Regulatory assessment is a key activity in registration and life cycle maintenance of Pharmaceutical and Biological products. It is important at various stages of product development such as: prior to Regulatory submission, during review and approval and post-approval of the product for global markets. Enabling manufacturers to understand the open points to be addressed and prepare the mitigation plan before Regulatory submission for any Pharmaceutical/Biological product, Regulatory assessment minimizes the possible rejections (e.g. Refuse to Receive [RTR]) from Health Authorities (HAs), delays in review cycles with deficiencies and accelerates the approval processes.
Regulatory assessment/gap analysis play a significant role in various Regulatory submissions such as:
  • Initial Submissions
  • Registered Dossier Extension
  • Legacy Product Re-Launch
  • Lifecycle Management
  • Electronic Conversions

Comments

Popular posts from this blog

Medical Device Regulation Report, Morocco, Registration

Medical Device Registration in Germany, IVDs, CE marking, EU MDR

Health Authority Queries – Responses | Interactions